Skip to main content

Table 4 Relationship between CCT2 and PDIA3 expression and clinicopathological characteristics and average survival of gallbladder SC/ASC patients

From: Clinicopathological features and CCT2 and PDIA2 expression in gallbladder squamous/adenosquamous carcinoma and gallbladder adenocarcinoma

Clinicopathological features Case number Average survival (months) χ2 P
Gender     
male 19 10.74(6 to 24) 0.767 0.381
female 27 9.85(4 to 24)   
Age (years)     
≤45 3 15.67(8 to 24) 2.023 0.155
>45 43 9.84(4 to 24)   
Pathological types     
SC 26 10.19(4 to 24) 0.223 0.637
ASC 20 10.25(4 to 24)   
Degree of differentiationa     
well-differentiated 16 7.04(4 to 11)   
moderately-Differentiated 24 8.92(4 to 18) 19.125 0.000
poorly-differentiated 6 5.83(4 to 9)   
Tumor maximum diameter (cm)     
≤ 3 cm 20 14.35(7 to 24) 31.337 0.620
> 3 cm 26 7.04(4 to 11)   
Gallbladder stones     
no 18 8.22(4 to 12) 3.730 0.053
yes 28 11.50(4 to 24)   
TNM stage     
I + II 12 17.00(9 to 24)   
III 20 9.20(7 to 15) 51.139 0.000
IV 14 5.86(4 to 8)   
Lymph node metastasis     
no 17 14.24(4 to 24) 16.219 0.000
yes 29 7.86(4 to 15)   
Invasion     
no 16 15.75(9 to 24) 32.271 0.000
yes 30 7.27(4 to 12)   
Surgical     
radical   16.64(10 to 24)   
palliative   8.50(6 to 12) 50.165 0.000
biopsy   6.00(4 to 8)   
CCT2     
- 23 12.96(6 to 24) 14.073 0.000
+ 33 7.48(4 to 12)   
PDIA3     
- 20 12.75(6 to 24) 7.011 0.008
+ 26 8.27(4 to 24)